Cargando…

Elevations in blood glucose before and after the appearance of islet autoantibodies in children

The etiology of type 1 diabetes has polygenic and environmental determinants that lead to autoimmune responses against pancreatic β cells and promote β cell death. The autoimmunity is considered silent without metabolic consequences until late preclinical stages,and it remains unknown how early in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warncke, Katharina, Weiss, Andreas, Achenbach, Peter, von dem Berge, Thekla, Berner, Reinhard, Casteels, Kristina, Groele, Lidia, Hatzikotoulas, Konstantinos, Hommel, Angela, Kordonouri, Olga, Elding Larsson, Helena, Lundgren, Markus, Marcus, Benjamin A., Snape, Matthew D., Szypowska, Agnieszka, Todd, John A., Bonifacio, Ezio, Ziegler, Anette-G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566912/ https://www.ncbi.nlm.nih.gov/pubmed/36250461 http://dx.doi.org/10.1172/JCI162123

Ejemplares similares

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2019)

Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2021)

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results
por: Winkler, Christiane, et al.
Publicado: (2019)

Birth and coming of age of islet autoantibodies
por: Bonifacio, E., et al.
Publicado: (2019)

Characterisation and clinical outcomes in children and adolescents with diabetes according to newly defined subgroups: a cohort study from the DPV registry
por: Warncke, Katharina, et al.
Publicado: (2023)

Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study
por: Raab, Jennifer, et al.
Publicado: (2016)

Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2020)

Age- and Islet Autoimmunity–Associated Differences in Amino Acid and Lipid Metabolites in Children at Risk for Type 1 Diabetes
por: Pflueger, Maren, et al.
Publicado: (2011)

Cesarean Section and Interferon-Induced Helicase Gene Polymorphisms Combine to Increase Childhood Type 1 Diabetes Risk
por: Bonifacio, Ezio, et al.
Publicado: (2011)

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022)

Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study
por: Li, Qian, et al.
Publicado: (2020)

Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12
por: Achenbach, Peter, et al.
Publicado: (2018)

Primary Dietary Intervention Study to Reduce the Risk of Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes: The BABYDIET study
por: Hummel, Sandra, et al.
Publicado: (2011)

Effects of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: protocol of a randomised controlled trial
por: Groele, Lidia, et al.
Publicado: (2017)

Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
por: Ng, Kenney, et al.
Publicado: (2022)

Activation of Islet Autoreactive Naïve T Cells in Infants Is Influenced by Homeostatic Mechanisms and Antigen-Presenting Capacity
por: Heninger, Anne-Kristin, et al.
Publicado: (2013)

Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2020)

Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2022)

The Use of Biomaterials in Islet Transplantation
por: Borg, Danielle J., et al.
Publicado: (2011)

Does Diabetes Appear in Distinct Phenotypes in Young People? Results of the Diabetes Mellitus Incidence Cohort Registry (DiMelli)
por: Warncke, Katharina, et al.
Publicado: (2013)

Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children
por: Bonifacio, Ezio, et al.
Publicado: (2018)

Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
por: Marzinotto, Ilaria, et al.
Publicado: (2023)

Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
por: Piemonti, Lorenzo, et al.
Publicado: (2013)

Skin manifestations in rare types of diabetes and other endocrine conditions
por: Reschke, Felix, et al.
Publicado: (2023)

CD8(+) T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage
por: Fuchs, Yannick F., et al.
Publicado: (2017)

Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection
por: Lin, Jake, et al.
Publicado: (2023)

Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
por: Andersson Svärd, Agnes, et al.
Publicado: (2020)

Electrochemiluminescence Assays for Human Islet Autoantibodies
por: Gu, Yong, et al.
Publicado: (2018)

Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young
por: Steck, Andrea K., et al.
Publicado: (2011)

A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes
por: Achenbach, Peter, et al.
Publicado: (2022)

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
por: Kwon, Bum Chul, et al.
Publicado: (2022)

Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity
por: Lundgren, Markus, et al.
Publicado: (2017)

Islet Autoantibody Testing: An End to the Trials and Tribulations?
por: Bingley, Polly J., et al.
Publicado: (2013)

Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
por: Gu, Yong, et al.
Publicado: (2017)

Prevalence of Islet Autoantibodies in Type 1 Diabetes
por: Dayal, Devi, et al.
Publicado: (2017)

Anti-Islet Autoantibodies in Type 1 Diabetes
por: Kawasaki, Eiji
Publicado: (2023)

Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis
por: Siraj, Elias S., et al.
Publicado: (2018)

Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases
por: Howson, J. M. M., et al.
Publicado: (2012)

Concentration and Activity of the Soluble Form of the Interleukin-7 Receptor α in Type 1 Diabetes Identifies an Interplay Between Hyperglycemia and Immune Function
por: Monti, Paolo, et al.
Publicado: (2013)

Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study
por: Elding Larsson, Helena, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bbjoge9qlqcmdcjesqmbjrveam